These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9664127)

  • 1. Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas.
    Sunahara M; Ichimiya S; Nimura Y; Takada N; Sakiyama S; Sato Y; Todo S; Adachi W; Amano J; Nakagawara A
    Int J Oncol; 1998 Aug; 13(2):319-23. PubMed ID: 9664127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
    Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
    Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
    Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas.
    Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
    Med Pediatr Oncol; 2001 Jan; 36(1):42-4. PubMed ID: 11464902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Refined mapping of loss of heterozygosity of 1p36.33-36.31 in sporadic colorectal carcinoma].
    Zhou CZ; Zheng HT; Qiu GQ; Zhang F; He L; Peng ZH
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1804-7. PubMed ID: 17054854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
    Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
    Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
    Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
    Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations of the KLF6 gene in colorectal cancers.
    Cho YG; Choi BJ; Kim CJ; Song JW; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
    APMIS; 2006 Jun; 114(6):458-64. PubMed ID: 16856969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region.
    Fang W; Piao Z; Simon D; Sheu JC; Huang S
    Genes Chromosomes Cancer; 2000 Jul; 28(3):269-75. PubMed ID: 10862032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
    Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
    Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
    Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
    J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?
    Gad S; Teboul D; Lièvre A; Goasguen N; Berger A; Beaune P; Laurent-Puig P
    BMC Cancer; 2004 Jul; 4():31. PubMed ID: 15245581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.
    Obermann EC; Diss TC; Hamoudi RA; Munson P; Wilkins BS; Camozzi ML; Isaacson PG; Du MQ; Dogan A
    J Pathol; 2004 Feb; 202(2):252-62. PubMed ID: 14743509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the FHIT gene in colorectal cancers.
    Thiagalingam S; Lisitsyn NA; Hamaguchi M; Wigler MH; Willson JK; Markowitz SD; Leach FS; Kinzler KW; Vogelstein B
    Cancer Res; 1996 Jul; 56(13):2936-9. PubMed ID: 8674044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p73, a gene related to p53, is not mutated in esophageal carcinomas.
    Nimura Y; Mihara M; Ichimiya S; Sakiyama S; Seki N; Ohira M; Nomura N; Fujimori M; Adachi W; Amano J; He M; Ping YM; Nakagawara A
    Int J Cancer; 1998 Nov; 78(4):437-40. PubMed ID: 9797131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of genetic changes in progression of colorectal cancer].
    Kuroda K; Watatani M; Yoshida T; Ieda S; Shindo K; Yasutomi M
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():164-8. PubMed ID: 8678562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
    Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K
    Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
    Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
    Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.